TABLE 1.
Study subjects’ characteristics1
| Sex, n |
Ethnicity, n |
||||||||
| Age, y | Weight, kg | Height, cm | BMI, kg/m2 | M | F | W | AA | O | |
| Study A | 57.9 ± 7.82 | 80.76 ± 16.16 | 171.1 ± 10.71 | 27.35 ± 2.78 | 5 | 5 | 9 | 1 | 0 |
| Study B | 58.1 ± 5.84 | 90.49 ± 21.17 | 170 ± 12.62 | 28.79 ± 5.99 | 4 | 6 | 7 | 3 | 0 |
1
Subjects were excluded if they had a history of cancer other than nonmelanoma skin cancer, previous major intestinal surgery, malabsorption or bleeding disorders, estrogen and/or progesterone replacement, supplemental vitamin D or nonsteroidal anti-inflammatory drug intake, or systemic or bowel inflammatory disorder. For more details, refer to Supplemental Table 1. AA, African American; O, other; W, white.
2
Mean ± SD (all such values).